Glenmark Pharmaceuticals Inc., USA, a part of Glenmark Pharmaceuticals Limited, has made a major step into the injectable drug market. In November 2025, the company launched its 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL Single-Dose Vial, entering a market with significant yearly sales. Read full news here:https://www.coherentmarketinsights.com/news/glenmark-pharmaceuticals-... https://www.coherentmarketinsights.com/news/glenmark-pharmaceuticals-usa-introduces-sodium-bicarbonate-injection-1806